H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024, H.R.4366, Consolidated Appropriations Act, 2024, and H.R.2882, Further Consolidated Appropriations Act, 2024, as they relate to PAHPA. Monitored issues related to pharmaceutical prices. Issues related to dialysis. Issues regarding the pharmaceutical supply chain. Issues concerning drug shortages. Issues concerning sterilization of medical devices. S. 2333, Pandemic and All-Hazards Preparedness and Response Act (PAHPA). H.R. 4421, the Preparing for All-Hazards and Pathogen Reauthorization Act (PAHPA). Monitored AI issues. Monitored cybersecurity issues. H.R. 7024, the Tax Relief for American Families and Workers Act, and issues related to the R&D tax credit. Issues related to ESRD. Monitored implementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Issues related to safe mobility. Issues related to reimbursement for breakthrough devices. Issues related to drug shortages. Issues related to extension of the hospital at home program.
BUD - Budget/Appropriations HCR - Health Issues TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
GREG D'ANGELO BRETT BAKER MARY BETH SAVARY TAYLOR BRETT BAKER MARY BETH SAVARY TAYLOR RACHEL JONES HENSLER BRETT BAKER GREG D'ANGELO MARY BETH SAVARY TAYLOR